MedPath

To Study The Efficacy OF Homoeopathic Medicine In Goitre

Phase 3
Conditions
Health Condition 1: E042- Nontoxic multinodular goiter
Registration Number
CTRI/2022/03/040827
Lead Sponsor
Dr Shagufta Naaz
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient with positive ultrasound result for evidence of multinodular goitre.

2. Patient with euthyroidism and subclinical hypothyroidism

Exclusion Criteria

1. Patient below the age of 18 years.

2. Evidence of malignant change in ultrasonography and Fine Needle Aspiration Cytology.

3. Patient with complications such as signs and symptoms of excessive mechanical obstruction and pressure effects on adjacent structures which

is diagnosed by necessary investigations.

4. Goitre with hyperthyroidism.

5. Patient with any diagnosed severe systemic illness.

6. Immunocompromised patients.

7. Pregnant and lactating mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the change in size and number of nodules in multinodular goitre by ultrasonography.Timepoint: 1 year follow up
Secondary Outcome Measures
NameTimeMethod
1. To find out the changes in the neck circumference. <br/ ><br> <br/ ><br>2. To find out the change in symptomatology after administration of Homoeopathic medications. <br/ ><br> <br/ ><br>3. To determine the change in thyroid profile. <br/ ><br> <br/ ><br>4. To find out commonly indicated Homoeopathic medicines effective in treatment of multinodular goitre.Timepoint: 1 year follow up
© Copyright 2025. All Rights Reserved by MedPath